Buprenorphine and Metabolite, Quantitative, Urine, by LCMS/MS analysis is a laboratory test designed to measure levels of buprenorphine, an opioid pain medication, and its metabolites in a urine sample. This test is commonly used in medical settings to monitor patients receiving buprenorphine therapy and to determine effective dosing. The analysis is performed using liquid chromatography-tandem mass spectrometry (LCMS/MS), a technique known for its accuracy and reliability in detecting low concentrations of compounds. The results help physicians evaluate patients’ response to treatment and monitor any potential misuse of the medication. They can also be used to guide dose adjustments or other measures to improve pain management.